Reasons to Retain Inari Medical Stock in Your Portfolio for Now [Yahoo! Finance]
Inari Medical, Inc. (NARI)
Company Research
Source: Yahoo! Finance
opportunity for its products, particularly in the venous thromboembolism (VTE) market, with significant growth prospects for its ClotTriever and FlowTriever products. (Source: Inari Medical, Inc. NARI is well poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system.) Inari Medical's top-line growth is primarily driven by its ClotTriever and FlowTriever products, which target patients with venous thromboembolism (VTE), with significant growth opportunities going forward, particularly in the underpenetrated VTE market in the United States. (Source: Inari Medical's top-line growth is primarily driven by its ClotTriever and FlowTriever products that target patients with venous thromboembolism (VTE) (with significant growth opportunities going forward).) The company's dependency on the adoption of its products, potential changes in reimbursement coverage, and the ongoing investigation by the U.S. Department of Jus
Show less
Read more
Impact Snapshot
Event Time:
NARI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NARI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NARI alerts
High impacting Inari Medical, Inc. news events
Weekly update
A roundup of the hottest topics
NARI
News
- Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Truist Financial Co. from $50.00 to $63.00. They now have a "hold" rating on the stock.MarketBeat
- Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Inari Medical, Inc. (NARI) and Encourages Stockholders to Learn More About the InvestigationAccesswire
- Inari Medical, Inc. (NASDAQ: NARI) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $75.00 price target on the stock.MarketBeat
- Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Investors to Inquire about Securities InvestigationAccesswire
- NARI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into Inari Medical, Inc. and Encourages Investors to Contact the FirmAccesswire
NARI
Earnings
- 10/28/24 - Miss
NARI
Sec Filings
- 12/20/24 - Form 4
- 12/18/24 - Form 4
- 12/12/24 - Form 144
- NARI's page on the SEC website